NEVVI Medicare utilization intelligence

← back

SHAH, MANISHMD NPI 1962792986 Clinician

Pain Management · LIMERICK, PA

Specialty Pain Management — from billed Medicare claims
In practice about 15 years since medical school (class of 2011, self-reported to CMS)
Location LIMERICK, PA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 33 codes billed · 11,485 disclosed services (CY2024 — most recent year in data)
Current groups
member of 4 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2022-03

Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg premiumpremium premiumpremium
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J1010 Injection, methylprednisolone acetate, 1 mg premiumpremium premiumpremium
96127 Assessment of emotional or behavioral problems premiumpremium premiumpremium
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month premiumpremium premiumpremium
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml premiumpremium premiumpremium
80307 Testing for presence of drug, by chemistry analyzers premiumpremium premiumpremium
64636 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint premiumpremium premiumpremium
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level premiumpremium premiumpremium
64493 Injection of lower or sacral spine facet joint using imaging guidance, single level premiumpremium premiumpremium
64494 Injection of lower or sacral spine facet joint using imaging guidance, second level premiumpremium premiumpremium
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms premiumpremium premiumpremium
64484 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level premiumpremium premiumpremium
64635 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint premiumpremium premiumpremium
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms premiumpremium premiumpremium
98980 Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month premiumpremium premiumpremium
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's premiumpremium premiumpremium
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance premiumpremium premiumpremium
0275T Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin premiumpremium premiumpremium
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms premiumpremium premiumpremium
62323 Injection of substance into lower spine canal using imaging guidance premiumpremium premiumpremium
64490 Injection of upper or middle spine facet joint using imaging guidance, single level premiumpremium premiumpremium
64491 Injection of upper or middle spine facet joint using imaging guidance, second level premiumpremium premiumpremium
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance premiumpremium premiumpremium
62321 Injection of substance into middle or upper spine canal using imaging guidance premiumpremium premiumpremium
20553 Injection of trigger points, 3 or more muscles premiumpremium premiumpremium
99406 Smoking and tobacco use intensive counseling, 4-10 minutes premiumpremium premiumpremium
J1030 Injection, methylprednisolone acetate, 40 mg premiumpremium premiumpremium
64628 Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.